Table of Contents

company-logo

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

Amicus Therapeutics Dividend Announcement

• Amicus Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Amicus Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Amicus Therapeutics Dividend History

Amicus Therapeutics Dividend Yield

Amicus Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Amicus Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Amicus Therapeutics Financial Ratios

P/E ratio-28.29
PEG ratio4.98
P/B ratio16.56
ROE-69.54%
Payout ratio0.00%
Current ratio3.15
Quick ratio2.42
Cash Ratio1.48

Amicus Therapeutics Dividend FAQ

Does Amicus Therapeutics stock pay dividends?
Amicus Therapeutics does not currently pay dividends to its shareholders.
Has Amicus Therapeutics ever paid a dividend?
No, Amicus Therapeutics has no a history of paying dividends to its shareholders. Amicus Therapeutics is not known for its dividend payments.
Why doesn't Amicus Therapeutics pay dividends?
There are several potential reasons why Amicus Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Amicus Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Amicus Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Amicus Therapeutics a dividend aristocrat?
Amicus Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Amicus Therapeutics a dividend king?
Amicus Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Amicus Therapeutics a dividend stock?
No, Amicus Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Amicus Therapeutics stocks?
To buy Amicus Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Amicus Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.